{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T03:04:52Z","timestamp":1783911892471,"version":"3.55.0"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2026,1,12]],"date-time":"2026-01-12T00:00:00Z","timestamp":1768176000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2026,1,12]],"date-time":"2026-01-12T00:00:00Z","timestamp":1768176000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"DOI":"10.13039\/501100010100","name":"\u00d8stfold Hospital Trust","doi-asserted-by":"crossref","award":["Project number AB3526"],"award-info":[{"award-number":["Project number AB3526"]}],"id":[{"id":"10.13039\/501100010100","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100016469","name":"Takeda Pharmaceuticals International","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100016469","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009032","name":"Pfizer UK","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009032","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012276","name":"Tillotts Pharma","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012276","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005366","name":"University of Oslo","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100005366","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Dig Dis Sci"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1007\/s10620-025-09661-0","type":"journal-article","created":{"date-parts":[[2026,1,12]],"date-time":"2026-01-12T18:03:07Z","timestamp":1768240987000},"page":"2476-2487","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Fatigue Trajectory During the First Year of an Inflammatory Bowel Disease Diagnosis, Results from the IBSEN III study"],"prefix":"10.1007","volume":"71","author":[{"ORCID":"https:\/\/orcid.org\/0009-0007-4041-2623","authenticated-orcid":false,"given":"Kristina I. Aass","family":"Holten","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomm","family":"Bernklev","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Randi","family":"Opheim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bj\u00f8rn C.","family":"Olsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ingunn","family":"Johansen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vibeke","family":"Strande","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raziye","family":"Boyar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00d8istein","family":"Hovde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roald","family":"Torp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"May-Bente","family":"Bengtson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tone B.","family":"Aabrekk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Trond Espen","family":"Detlie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Svein Oskar","family":"Frigstad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vendel A.","family":"Kristensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Milada","family":"Hagen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Magne","family":"Henriksen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gert","family":"Huppertz-Hauss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marte Lie","family":"H\u00f8ivik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lars-Petter","family":"Jelsness-J\u00f8rgensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,12]]},"reference":[{"key":"9661_CR1","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1038\/nature10209","volume":"474","author":"B Khor","year":"2011","unstructured":"Khor B, Gardet A, Xavier RJ. Genetics and pathogenesis of inflammatory bowel disease. Nature. 2011;474:307\u2013317.","journal-title":"Nature."},{"key":"9661_CR2","doi-asserted-by":"publisher","first-page":"1424926","DOI":"10.3389\/fmed.2024.1424926","volume":"11","author":"M Truyens","year":"2024","unstructured":"Truyens M, Lernout H, De Vos M, Laukens D, Lobaton T. Unraveling the fatigue puzzle: insights into the pathogenesis and management of IBD-related fatigue including the role of the gut-brain axis. Front Med (Lausanne). 2024;11:1424926.","journal-title":"Front Med (Lausanne)."},{"key":"9661_CR3","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1097\/MOG.0000000000000644","volume":"36","author":"T Qazi","year":"2020","unstructured":"Qazi T. Fatigue in inflammatory bowel disease: a problematic ailment. Curr Opin Gastroenterol. 2020;36:284\u2013294.","journal-title":"Curr Opin Gastroenterol."},{"key":"9661_CR4","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1111\/apt.12205","volume":"37","author":"W Czuber-Dochan","year":"2013","unstructured":"Czuber-Dochan W, Ream E, Norton C. Review article: Description and management of fatigue in inflammatory bowel disease. Aliment Pharmacol Ther. 2013;37:505\u2013516.","journal-title":"Aliment Pharmacol Ther."},{"key":"9661_CR5","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1111\/apt.16465","volume":"54","author":"JJ McGing","year":"2021","unstructured":"McGing JJ, Radford SJ, Francis ST, Serres S, Greenhaff PL, Moran GW. Review article: The aetiology of fatigue in inflammatory bowel disease and potential therapeutic management strategies. Aliment Pharmacol Ther. 2021;54:368\u2013387.","journal-title":"Aliment Pharmacol Ther."},{"key":"9661_CR6","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1111\/apt.16145","volume":"53","author":"P Schreiner","year":"2021","unstructured":"Schreiner P, Rossel JB, Biedermann L, Valko PO, Baumann CR, Greuter T et al. Fatigue in inflammatory bowel disease and its impact on daily activities. Aliment Pharmacol Ther. 2021;53:138\u2013149.","journal-title":"Aliment Pharmacol Ther."},{"key":"9661_CR7","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1136\/flgastro-2019-101355","volume":"12","author":"SJ Radford","year":"2021","unstructured":"Radford SJ, McGing J, Czuber-Dochan W, Moran G. Systematic review: the impact of inflammatory bowel disease-related fatigue on health-related quality of life. Frontline Gastroenterol. 2021;12:11\u201321.","journal-title":"Frontline Gastroenterol."},{"key":"9661_CR8","doi-asserted-by":"publisher","first-page":"1919","DOI":"10.1093\/ibd\/izab007","volume":"27","author":"B Klusmann","year":"2021","unstructured":"Klusmann B, Fleer J, Tovote KA, Weersma RK, van Dullemen HM, Dijkstra G et al. Trajectories of Fatigue in Inflammatory Bowel Disease. Inflamm Bowel Dis. 2021;27:1919\u20131930.","journal-title":"Inflamm Bowel Dis."},{"key":"9661_CR9","doi-asserted-by":"crossref","unstructured":"D\u2019Silva A, Fox DE, Nasser Y, Vallance JK, Quinn RR, Ronksley PE, et al. Prevalence and Risk Factors for Fatigue in Adults With Inflammatory Bowel Disease: A Systematic Review With Meta-Analysis. Clin Gastroenterol Hepatol. 2022;20(5):995\u20131009 e7.","DOI":"10.1016\/j.cgh.2021.06.034"},{"key":"9661_CR10","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1007\/s12325-019-01151-w","volume":"37","author":"A Nocerino","year":"2020","unstructured":"Nocerino A, Nguyen A, Agrawal M, Mone A, Lakhani K, Swaminath A. Fatigue in Inflammatory Bowel Diseases: Etiologies and Management. Adv Ther. 2020;37:97\u2013112.","journal-title":"Adv Ther."},{"key":"9661_CR11","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1186\/s10020-023-00679-6","volume":"29","author":"I Kvivik","year":"2023","unstructured":"Kvivik I, Grimstad T, Bardsen K, Jonsson G, Kvaloy JT, Omdal R. High mobility group box 1 and a network of other biomolecules influence fatigue in patients with Crohn\u2019s disease. Mol Med. 2023;29:81.","journal-title":"Mol Med."},{"key":"9661_CR12","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1080\/00365521.2021.1922746","volume":"56","author":"VA Kristensen","year":"2021","unstructured":"Kristensen VA, Opheim R, Perminow G, Huppertz-Hauss G, Detlie TE, Lund C et al. Inflammatory bowel disease in South-Eastern Norway III (IBSEN III): a new population-based inception cohort study from South-Eastern Norway. Scand J Gastroenterol. 2021;56:899\u2013905.","journal-title":"Scand J Gastroenterol."},{"key":"9661_CR13","doi-asserted-by":"crossref","unstructured":"Lennard-Jones JE. Classification of inflammatory bowel disease. Scand J Gastroenterol Suppl. 1989;170:2\u20136; discussion 16\u20139.","DOI":"10.3109\/00365528909091339"},{"key":"9661_CR14","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1136\/gut.2005.082909","volume":"55","author":"J Satsangi","year":"2006","unstructured":"Satsangi J, Silverberg MS, Vermeire S, Colombel JF. The Montreal classification of inflammatory bowel disease: controversies, consensus, and implications. Gut. 2006;55:749\u2013753.","journal-title":"Gut."},{"key":"9661_CR15","doi-asserted-by":"crossref","unstructured":"Louis E, Collard A, Oger AF, Degroote E, Aboul Nasr El Yafi FA, Belaiche J. Behaviour of Crohn\u2019s disease according to the Vienna classification: changing pattern over the course of the disease. Gut. 2001;49(6):777\u201382.","DOI":"10.1136\/gut.49.6.777"},{"key":"9661_CR16","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1016\/S0016-5107(04)01878-4","volume":"60","author":"M Daperno","year":"2004","unstructured":"Daperno M, D\u2019Haens G, Van Assche G, Baert F, Bulois P, Maunoury V et al. Development and validation of a new, simplified endoscopic activity score for Crohn\u2019s disease: the SES-CD. Gastrointest Endosc. 2004;60:505\u2013512.","journal-title":"Gastrointest Endosc."},{"key":"9661_CR17","first-page":"462","volume":"35","author":"MD Ruscio","year":"2022","unstructured":"Ruscio MD, Cedola M, Mangone M, Brighi S. How to assess endoscopic disease activity in ulcerative colitis in 2022. Ann Gastroenterol. 2022;35:462\u2013470.","journal-title":"Ann Gastroenterol."},{"key":"9661_CR18","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1093\/ecco-jcc\/jjy113","volume":"13","author":"C Maaser","year":"2019","unstructured":"Maaser C, Sturm A, Vavricka SR, Kucharzik T, Fiorino G, Annese V et al. ECCO-ESGAR Guideline for Diagnostic Assessment in IBD Part 1: Initial diagnosis, monitoring of known IBD, detection of complications. J Crohns Colitis. 2019;13:144\u2013164.","journal-title":"J Crohns Colitis."},{"key":"9661_CR19","doi-asserted-by":"publisher","first-page":"2218","DOI":"10.1002\/ibd.22917","volume":"18","author":"G D\u2019Haens","year":"2012","unstructured":"D\u2019Haens G, Ferrante M, Vermeire S, Baert F, Noman M, Moortgat L et al. Fecal calprotectin is a surrogate marker for endoscopic lesions in inflammatory bowel disease. Inflamm Bowel Dis. 2012;18:2218\u20132224.","journal-title":"Inflamm Bowel Dis."},{"key":"9661_CR20","doi-asserted-by":"publisher","first-page":"968","DOI":"10.1093\/ije\/dys095","volume":"42","author":"S Krokstad","year":"2013","unstructured":"Krokstad S, Langhammer A, Hveem K, Holmen TL, Midthjell K, Stene TR et al. Cohort Profile: the HUNT Study. Norway. Int J Epidemiol. 2013;42:968\u2013977.","journal-title":"Norway. Int J Epidemiol."},{"key":"9661_CR21","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/0022-3999(93)90081-P","volume":"37","author":"T Chalder","year":"1993","unstructured":"Chalder T, Berelowitz G, Pawlikowska T, Watts L, Wessely S, Wright D et al. Development of a fatigue scale. J Psychosom Res. 1993;37:147\u2013153.","journal-title":"J Psychosom Res."},{"key":"9661_CR22","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/S0022-3999(97)00291-2","volume":"45","author":"JH Loge","year":"1998","unstructured":"Loge JH, Ekeberg O, Kaasa S. Fatigue in the general Norwegian population: normative data and associations. J Psychosom Res. 1998;45:53\u201365.","journal-title":"J Psychosom Res."},{"key":"9661_CR23","doi-asserted-by":"publisher","first-page":"1740","DOI":"10.1093\/ibd\/izaa338","volume":"27","author":"NZ Borren","year":"2021","unstructured":"Borren NZ, Long MD, Sandler RS, Ananthakrishnan AN. Longitudinal Trajectory of Fatigue in Patients With Inflammatory Bowel Disease: A Prospective Study. Inflamm Bowel Dis. 2021;27:1740\u20131746.","journal-title":"Inflamm Bowel Dis."},{"key":"9661_CR24","doi-asserted-by":"crossref","unstructured":"Bredero QM, Fleer J, Blom DM, Bourgonje AR, Dijkstra G, Schroevers MJ. The substantial role of sleep, stress and physical activity in persistent high levels of fatigue in patients with inflammatory bowel disease: A longitudinal trajectory study. J Crohns Colitis. 2024.","DOI":"10.1093\/ecco-jcc\/jjae163"},{"key":"9661_CR25","doi-asserted-by":"publisher","first-page":"1140","DOI":"10.1016\/j.cgh.2013.03.031","volume":"11","author":"LA Graff","year":"2013","unstructured":"Graff LA, Clara I, Walker JR, Lix L, Carr R, Miller N et al. Changes in fatigue over 2 years are associated with activity of inflammatory bowel disease and psychological factors. Clin Gastroenterol Hepatol. 2013;11:1140\u20131146.","journal-title":"Clin Gastroenterol Hepatol."},{"key":"9661_CR26","doi-asserted-by":"publisher","first-page":"1781","DOI":"10.1093\/ecco-jcc\/jjad094","volume":"17","author":"KIA Holten","year":"2023","unstructured":"Holten KIA, Bernklev T, Opheim R, Johansen I, Olsen BC, Lund C et al. Fatigue in Patients with Newly Diagnosed Inflammatory Bowel Disease: Results from a Prospective Inception Cohort, the IBSEN III Study. J Crohns Colitis. 2023;17:1781\u20131790.","journal-title":"J Crohns Colitis."},{"key":"9661_CR27","doi-asserted-by":"crossref","unstructured":"Holten KA, Bernklev T, Opheim R, Olsen BC, Detlie TE, Strande V, et al. Fatigue in patients with inflammatory bowel disease in remission one year after diagnosis (the IBSEN III study). J Crohns Colitis. 2024.","DOI":"10.1093\/ecco-jcc\/jjae170"},{"key":"9661_CR28","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1093\/ecco-jcc\/jjz180","volume":"14","author":"J Torres","year":"2020","unstructured":"Torres J, Bonovas S, Doherty G, Kucharzik T, Gisbert JP, Raine T et al. ECCO Guidelines on Therapeutics in Crohn\u2019s Disease: Medical Treatment. J Crohns Colitis. 2020;14:4\u201322.","journal-title":"J Crohns Colitis."},{"key":"9661_CR29","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1093\/ecco-jcc\/jjab178","volume":"16","author":"T Raine","year":"2022","unstructured":"Raine T, Bonovas S, Burisch J, Kucharzik T, Adamina M, Annese V et al. ECCO Guidelines on Therapeutics in Ulcerative Colitis: Medical Treatment. J Crohns Colitis. 2022;16:2\u201317.","journal-title":"J Crohns Colitis."},{"key":"9661_CR30","doi-asserted-by":"crossref","unstructured":"Farrell D, Artom M, Czuber-Dochan W, Jelsness-Jorgensen LP, Norton C, Savage E. Interventions for fatigue in inflammatory bowel disease. Cochrane Database Syst Rev. 2020;4:CD012005.","DOI":"10.1002\/14651858.CD012005.pub2"},{"key":"9661_CR31","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1007\/s40265-023-01888-3","volume":"83","author":"BM Skjellerudsveen","year":"2023","unstructured":"Skjellerudsveen BM, Skoie IM, Dalen I, Grimstad T, Omdal R. The Effect of Biological Treatment on Fatigue in Inflammatory Bowel Disease: A Systematic Review and Meta-analysis. Drugs. 2023;83:909\u2013921.","journal-title":"Drugs."},{"key":"9661_CR32","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1038\/s41575-018-0091-9","volume":"16","author":"NZ Borren","year":"2019","unstructured":"Borren NZ, van der Woude CJ, Ananthakrishnan AN. Fatigue in IBD: epidemiology, pathophysiology and management. Nat Rev Gastroenterol Hepatol. 2019;16:247\u2013259.","journal-title":"Nat Rev Gastroenterol Hepatol."},{"key":"9661_CR33","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1093\/ecco-jcc\/jjz148","volume":"14","author":"NZ Borren","year":"2020","unstructured":"Borren NZ, Tan W, Colizzo FP, Luther J, Garber JJ, Khalili H et al. Longitudinal Trajectory of Fatigue With Initiation of Biologic Therapy in Inflammatory Bowel Diseases: A Prospective Cohort Study. J Crohns Colitis. 2020;14:309\u2013315.","journal-title":"J Crohns Colitis."},{"key":"9661_CR34","doi-asserted-by":"publisher","first-page":"23348","DOI":"10.1038\/s41598-024-74683-z","volume":"14","author":"NH Park","year":"2024","unstructured":"Park NH, Kang YE, Yoon JH, Ahn YC, Lee EJ, Park BJ et al. Comparative study for fatigue prevalence in subjects with diseases: a systematic review and meta-analysis. Sci Rep. 2024;14:23348.","journal-title":"Sci Rep."},{"key":"9661_CR35","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1038\/s41575-022-00634-6","volume":"19","author":"TH Bisgaard","year":"2022","unstructured":"Bisgaard TH, Allin KH, Keefer L, Ananthakrishnan AN, Jess T. Depression and anxiety in inflammatory bowel disease: epidemiology, mechanisms and treatment. Nat Rev Gastroenterol Hepatol. 2022;19:717\u2013726.","journal-title":"Nat Rev Gastroenterol Hepatol."},{"key":"9661_CR36","doi-asserted-by":"publisher","first-page":"1078","DOI":"10.1097\/00005650-199910000-00011","volume":"37","author":"JM Bensing","year":"1999","unstructured":"Bensing JM, Hulsman RL, Schreurs KM. Gender differences in fatigue: biopsychosocial factors relating to fatigue in men and women. Med Care. 1999;37:1078\u20131083.","journal-title":"Med Care."},{"key":"9661_CR37","doi-asserted-by":"publisher","first-page":"368504221135469","DOI":"10.1177\/00368504221135469","volume":"105","author":"NZ Farhane-Medina","year":"2022","unstructured":"Farhane-Medina NZ, Luque B, Tabernero C, Castillo-Mayen R. Factors associated with gender and sex differences in anxiety prevalence and comorbidity: A systematic review. Sci Prog. 2022;105:368504221135469.","journal-title":"Sci Prog."},{"key":"9661_CR38","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1037\/bul0000102","volume":"143","author":"RH Salk","year":"2017","unstructured":"Salk RH, Hyde JS, Abramson LY. Gender differences in depression in representative national samples: Meta-analyses of diagnoses and symptoms. Psychol Bull. 2017;143:783\u2013822.","journal-title":"Psychol Bull."},{"key":"9661_CR39","doi-asserted-by":"publisher","first-page":"1370","DOI":"10.1053\/j.gastro.2021.12.246","volume":"162","author":"B Verstockt","year":"2022","unstructured":"Verstockt B, Bressler B, Martinez-Lozano H, McGovern D, Silverberg MS. Time to Revisit Disease Classification in Inflammatory Bowel Disease: Is the Current Classification of Inflammatory Bowel Disease Good Enough for Optimal Clinical Management? Gastroenterology. 2022;162:1370\u20131382.","journal-title":"Gastroenterology."},{"key":"9661_CR40","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCHEARTFAILURE.124.011728","volume":"18","author":"S Gan","year":"2025","unstructured":"Gan S, Azzo JD, Zhao L, Pourmussa B, Dib MJ, Salman O et al. Transferrin Saturation, Serum Iron, and Ferritin in Heart Failure: Prognostic Significance and Proteomic Associations. Circ Heart Fail. 2025;18:e011728.","journal-title":"Circ Heart Fail."},{"key":"9661_CR41","doi-asserted-by":"publisher","first-page":"27","DOI":"10.3389\/fmolb.2016.00027","volume":"3","author":"L Hannibal","year":"2016","unstructured":"Hannibal L, Lysne V, Bjorke-Monsen AL, Behringer S, Grunert SC, Spiekerkoetter U et al. Biomarkers and Algorithms for the Diagnosis of Vitamin B12 Deficiency. Front Mol Biosci. 2016;3:27.","journal-title":"Front Mol Biosci."},{"key":"9661_CR42","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1210\/jc.2010-2704","volume":"96","author":"AC Ross","year":"2011","unstructured":"Ross AC, Manson JE, Abrams SA, Aloia JF, Brannon PM, Clinton SK et al. The 2011 report on dietary reference intakes for calcium and vitamin D from the Institute of Medicine: what clinicians need to know. J Clin Endocrinol Metab. 2011;96:53\u201358.","journal-title":"J Clin Endocrinol Metab."}],"container-title":["Digestive Diseases and Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-025-09661-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10620-025-09661-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-025-09661-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T02:26:36Z","timestamp":1783909596000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10620-025-09661-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,12]]},"references-count":42,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["9661"],"URL":"https:\/\/doi.org\/10.1007\/s10620-025-09661-0","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-7562844\/v1","asserted-by":"object"}]},"ISSN":["0163-2116","1573-2568"],"issn-type":[{"value":"0163-2116","type":"print"},{"value":"1573-2568","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,12]]},"assertion":[{"value":"8 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"T.B, R.O, B.C.O, I.J, M.B.B, T.B.A, R.T, M.Ha, \u00d8.H, R.B, M.He, G.H.H, L.P.J.J and K.A.H. declare that they have no conflicts of interest. T.E.D: Served as a speaker, consultant or advisory board member for AbbVie, Ferring, Johnson&Johnsen, Pfizer, Pharmacosmos, Takeda, Tillotts, and Vifor Pharma. He has received unrestricted research grants from AbbVie, and Pharmacosmos. S.O.F: Personal fees from Takeda, Galapagos, Jansen-Cilag, Abbvie, Pharmacosmos and Bristol-Myers-Squibb. V.S: Sponsored by funds from Takeda. V.A.K: Consultant for Janssen-Cilag, scientific advisory board and consultant for Takeda, speaker for Thermo Fischer, advisory board for Tillotts Pharma. M.L.H: Investigator-initiated research grants from Takeda, Pfizer, Tilllotts, Ferring and Janssen. Speaker honoraria from Takeda, Tillotts, Ferring, AbbVie, Galapagos, MSD and Meda. Advisory board for Takeda, Galapagos, MSD, Lilly, Janssen, Pfizer and AbbVie.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The IBSEN III study was approved by the Southeast Regional Committee for Medical and Health Research Ethics (Ref 2015\/946\u20133). Signed informed consent was obtained from all patients before study inclusion, with the possibility to withdraw consent at any point during the observational period.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}